Immune-Function Medical Cannabis Studies

A

• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• asthma (1)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)

B

• batten-disease (6)

• benefits (9)

• breast-cancer (7)

C

• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)

D

• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)

E

• emesis (6)

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)

F

• fibromyalgia (2)

• fibrosis (1)

G

• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

• glioma (9)

H

• health-care (1)

• hiv (7)

• huntingtons-disease (1)

I

• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)

K

• krabbe-disease (4)

L

• liver (2)

• lung-cancer (2)

• lupus (1)

M

• memory (3)

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)

N

• national-institute-on-drug-abuse-nida (1)

• nausea (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)

P

• pain (29)

• pancreatitis (1)

• prostate-cancer (2)

S

• schizophrenia (2)

• skin (1)

• sports (3)

T

• thc (1)

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)
  • Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties (2010)

    View study

  • Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (2010)

    This research focused on the study of the apoptotic mechanisms of cannabinoid-mediated immunosuppression in different immune cell populations and we will evaluate how the activation of CB2 gives a novel therapeutic modality against inflammatory and autoimmune diseases, as well as malignant neoplasms of the immune system, without exercising the unpleasant psychotropic View study

  • Cannabinoids and the immune system (2001)

    This research was based on the study of cannabinoids and the immune system. It could be concluded that these drugs have subtle but complex effects on the function of immune cells and that part of the activity of the drugs is mediated by the cannabinoid receptors expressed in the various subtypes of immune cells. View study

  • Cannabinoids, Immune System and Cytokine Network (2006)

    There is sufficient evidence to suggest that the cannabinoid system affects significantly all the components of the immune response machinery and impacts the functioning also of the cytokine network. View study

  • D9-Tetrahydrocannabinol-Induced Apoptosis in the Thymus and Spleen as a Mechanism of Immunosuppression in Vitro and in Vivo (2002)

    Through this study, we hypothesized that exposure to 9 �Tetrahydrocannabinol (THC) leads to the induction of apoptosis in lymphocyte populations. The results suggest that in vivo exposure to THC can lead to a significant suppresion of the immune response by induction of apoptosis. View study

  • Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations (1995)

    In this investigation, the distribution patterns for the transcripts of both CB1 and CB2 in human immune cells and in various human tissues are reported, as analyzed by a highly sensitive and quantitative PCR-based method. The results found in this study show that CB1 and CB2 can be considered tissue selective antigens of the central nervous system and the immune system, respectively, and cannabinoids can exert specific actions mediated by the receptor in the immune system through the CB2 receptor. View study

  • Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists (2010)

    The immunological effects of cannabinoids should be considered in the context of each prescription decision. Evidence is shown that the immunological effects of cannabinoid receptor agonists and antagonists are quite relevant to the spectrum of disorders for which the therapeutic products of cannabinoids are currently offered. View study

  • Interaction Between The Protective Effects Of Cannabidiol And Palmitoylethanolamide In Experimental Model Of Multiple Sclerosis In C57BL/6 Mice (2015)

    According to the results of this study, cannabidiol (CBD) and palmitoylethanolamide (PEA), non-psychoactive cannabinoids (CB), attenuate neurobehavioral deficits, histological damage and expression of inflammatory cytokines in animals immunized with glycoprotein oligodendrocyte myelin (MOG) ). View study